Cargando…

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome

INTRODUCTION: Because of the shortage of available organs for renal transplantation, strategies enabling the safe use of organs from donors with potential chronic infections such as hepatitis C are necessary. The aim of this study was to analyze the outcome of renal transplant donation from hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowak, Knut Michael, Witzke, Oliver, Sotiropoulos, Georgios C., Benkö, Tamas, Fiedler, Melanie, Timm, Jörg, Kribben, Andreas, Wilde, Benjamin, Saner, Fuat, Paul, Andreas, Treckmann, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678640/ https://www.ncbi.nlm.nih.gov/pubmed/29142940 http://dx.doi.org/10.1016/j.ekir.2016.09.058

Ejemplares similares

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

Evaluation of hemostasis in patients with end-stage renal disease
por: Gäckler, Anja, et al.
Publicado: (2019)

Aspergillus Tracheobronchitis Causing Subtotal Tracheal Stenosis in a Liver Transplant Recipient
por: Radunz, Sonia, et al.
Publicado: (2013)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Oxygen Persufflation in Liver Transplantation Results of a Randomized Controlled Trial
por: Gallinat, Anja, et al.
Publicado: (2019)

One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation
por: Benkö, T., et al.
Publicado: (2018)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Genotypic resistance testing of HCV – is there a clinical need?
por: Walker, Andreas, et al.
Publicado: (2016)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
por: Benkö, Tamás, et al.
Publicado: (2022)

Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
por: Steinbrink, Julie M., et al.
Publicado: (2023)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
por: Eisenberger, Ute, et al.
Publicado: (2018)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction
por: Benkö, Tamas, et al.
Publicado: (2019)

Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
por: Chen, Ruoyang, et al.
Publicado: (2021)

Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
por: Eckman, Mark H., et al.
Publicado: (2021)

Dilemma of HCV Infection in Renal Transplant Recipients
por: Ashry Ahmed Gheith, Osama
Publicado: (2011)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Lymph Node Staging in Perihilar Cholangiocarcinoma: The Key to the Big Picture
por: Rogacka, Nina A., et al.
Publicado: (2023)

Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis
por: Husen, Peri, et al.
Publicado: (2019)

Heterogeneous distribution of HCV genotypes and growing menace of mixed HCV infection in blood recipients in Khyber Pakhtunkhwa
por: Attaullah, Sobia, et al.
Publicado: (2017)

The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation
por: Wieczorek-Godlewska, Renata, et al.
Publicado: (2017)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Neurologic complications in adult living donor liver transplant patients: an underestimated factor?
por: Saner, Fuat Hakan, et al.
Publicado: (2009)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Membranoproliferative glomerulonephritis associated with HCV infection in native kidneys and renal allograft.
por: Jeong, H. J., et al.
Publicado: (1998)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients
por: Neumann, Ulf, et al.
Publicado: (2012)

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015)

Citrate shows protective effects on cardiovascular and renal function in ischemia-induced acute kidney injury
por: Bienholz, Anja, et al.
Publicado: (2017)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Donor, Recipient and Surgeon Sex and Sex-Concordance and their Impact on Liver Transplant Outcome
por: Mazilescu, Laura Ioana, et al.
Publicado: (2023)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation
por: Da, Ben L., et al.
Publicado: (2020)

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
por: Bulfoni, Michela, et al.
Publicado: (2021)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1sr759nopuqgmmdqqah4vfhgsn